(ET) to discuss these resultsand other matters related to the businesses when Kathy Ordoñez, Chief ExecutiveOfficer, and Ugo DeBlasi, Chief Financial Officer, will make prepared remarksand answer questions from securities analysts and investment professionals.Investors, securities analysts, representatives of the media and otherinterested parties who would like to participate should dial (866) 510-0676, or(617) 597-5361 for international callers, and enter passcode 62798924 at anytime from 4:15 p.m (ET) until the end of the call This conference call willalso be webcast. Interested parties who wish to listen to the webcast shouldvisit the "Media and Investors" section on A digital recordingwill be available approximately two hours after the completion of the conferencecall on May 6 until May 20, 2009. Interested parties should call (888) 286-8010,or (617) 801-6888 for international callers, and enter passcode 15169117. About CeleraCelera is a healthcare business delivering personalized disease managementthrough a combination of products and services incorporating proprietarydiscoveries. Berkeley HeartLab, a subsidiary of Celera, offers services topredict cardiovascular disease risk and improve patient management. Celera alsocommercializes a wide range of molecular diagnostic products through Abbott andhas licensed other relevant diagnostic technologies developed to providepersonalized disease management in cancer and liver diseases. Information aboutCelera Corporation, including reports and other information filed by the companywith the Securities and Exchange Commission, is available at http:// Forward-Looking StatementsCertain statements in this press release, including the "Outlook for 2009"section, are forward-looking.
These may be identified by the use offorward-looking words or phrases such as "believe," "expect," "will," "should,""anticipate," and "intend," among others. These forward-looking statements arebased on Celera`s current expectations. The Private Securities Litigation ReformAct of 1995 provides a "safe harbor" for such forward-looking statements. Inorder to comply with the terms of the safe harbor, Celera notes that a varietyof factors could cause actual results and experience to differ materially fromthe anticipated results or other expectations expressed in such forward-lookingstatements. The foregoing list sets forth some, but notall, of the factors that could affect our ability to achieve results describedin any forward-looking statements.
For additional information about risks anduncertainties we face and a discussion of our financial statements andfootnotes, see documents we file with the SEC, including our transition reporton Form 10-KT. We assume no obligation and expressly disclaim any duty to updateforward-looking statements to reflect events or circumstances after the date ofthis press release or to reflect the occurrence of subsequent events Copyright© 2009 Celera Corporation All Rights Reserved. Celera is a registeredtrademark of Celera Corporation or its subsidiaries in the U S. Thestatement of operations forthe three months endedMarch 31, 2008 was preparedon a combined basis and included in Applera's consolidating financial information. The statementof operations for the threemonths ended March 28, 2009reflects the consolidated results of Celera Corporation following the completion of the split-offfrom Applera on July 1, 2008.